Balchem Corporation (BL9B)
XMUN 
Summary
Balchem: It's A Buy From Me After Posting Strong Q2 Results
Balchem Corporation posted Q2 results, with EPS of $1.49 beating estimates by $0.07, while surpassing the consensus by $15M and was up 11% YoY. All areas of the business posted impressive results, as the minimum revenue growth for a segment was 8.9%, while the peak was 15% in Animal Nutrition & Health. The stock appears to be trading for a ~9% discount to its fair value right now based on my FCF valuation model.
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem Corporation (BL9B) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Balchem Corporation ever had a stock split?
Balchem Corporation Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Theodore L. Harris CEO | XMUN Exchange | US0576652004 ISIN |
| US Country | 1,379 Employees | 23 Dec 2025 Last Dividend | 21 Jan 2010 Last Split | 3 Jun 1986 IPO Date |
Overview
Balchem Corporation is a leading company in the development, manufacturing, and marketing of specialty performance ingredients and products, catering to a diverse range of industries globally. Since its inception in 1967, Balchem has been dedicated to serving the nutritional, food, pharmaceutical, animal health, plant nutrition, industrial markets, and medical device sterilization. The company operates through three business segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products, ensuring a comprehensive approach to innovation and customer service. With its headquarters in Montvale, New Jersey, Balchem aims to leverage its extensive expertise to advance health, nutrition, and safety across various applications worldwide.
Products and Services
Balchem Corporation offers a wide variety of products and services across its diversified segments:
- Human Nutrition & Health: This segment focuses on supplying ingredients to the food and beverage industry. Among its offerings are:
- Spray dried and emulsified powders, designed for various food applications.
- Extrusion and agglomeration technologies for improved ingredient delivery.
- Blended lipid systems and liquid flavor delivery systems for enhanced food quality.
- Juice and dairy bases, chocolate systems, cereal systems, ice cream bases, and variegates to enrich consumer products.
- Specialty vitamin K2 and microencapsulation solutions targeting health and nutrition applications.
- Human grade choline nutrients and mineral amino acid chelated products aimed at optimizing nutrition and health.
- Animal Nutrition & Health: This segment delivers solutions aimed at improving the health and production of animals, including:
- Microencapsulated products designed to enhance health and milk production in ruminant animals.
- Chelation technology that offers enhanced nutrient absorption for various animal species.
- Methylsulfonylmethane (MSM) for dietary supplements.
- Choline chloride, serving as a vital nutrient for monogastric animal health.
- Specialty Products: This segment focuses on products for more specialized markets, such as healthcare and agriculture, offering:
- Ethylene oxide and ammonia for the healthcare industry, specifically for device sterilization.
- Single use canisters for sterilizing reusable medical devices.
- Propylene oxide as a fumigant to control insects and microbiological spoilage in food products like nuts, spices, and dried fruits.
- Chelated minerals for enhancing the growth of high-value crops.
Balchem sells its diverse range of products through a combination of its sales force, independent distributors, and sales agents, ensuring a broad reach and efficient delivery to its global customer base.
